白内障超声乳化术对糖尿病患者眼表影响的研究进展

doi:10.3969/j.issn.1000-8535.2023.10.018

摘要/Abstract

摘要： 糖尿病已成为全球最严重的健康问题之一。需要白内障手术的糖尿病患者也日益增多,虽然糖尿病的眼表并发症很常见,但由于糖尿病患者全身和眼部疾病十分复杂,使得眼前段如角结膜和泪腺的糖尿病并发症往往被忽视。糖尿病患者白内障超声乳化术有引发或加重眼前节疾病的风险,包括干眼病（DED）、角膜上皮糜烂、上皮缺损迁延不愈,甚至威胁视力的角膜溃疡。这些风险里最为常见的是DED,并且可能因白内障超声乳化手术而加重。眼科医生需要在手术前预先评估已存在的DED是否需要术前治疗,并且需要注意在已存在 DED 的情况下,各项术前检查数据测量的准确性会降低,以及尽可能减少对眼表造成损害的各种手术因素;并考虑通过管理减少术后 DED。本综述就评估白内障超声乳化术对合并糖尿病的老年性白内障患者的眼表术中的影响因素进行分析。

关键词: 超声乳化白内障摘除术, 糖尿病, 眼表, 干眼病

Abstract: Diabetes mellitus(DM)has become one of the most serious health problems in the world. The number of diabetic patients requiring cataract surgery is also increasing. Although ocular surface complications of DM are common,the complexity of systemic and ocular disease in diabetic patients makes diabetic complications in the anterior segment,such as the cornea and lacrimal gland,often be overlooked. Phacoemulsification in diabetic patients carries the risk of triggering or exacerbating ocular segment disease,including dry eye disease,corneal epithelial erosion,persistent epithelial defects and even vision-threatening corneal ulcers. The most common of these risks is dry eye disease,and it can be exacerbated by cataract phacoemulsification. Ophthalmologists need to preemptively assess the need for preoperative treatment of pre-existing dry eye disease(DED),be aware of the reduced accuracy of preoperative data measurements in the presence of DED,and minimize surgical factors that can damage the ocular surface;and consider management to reduce postoperative DED. In this review,we analyze the factors that influence phacoemulsification in ocular surface surgery for senile cataract patients with diabetes.

Key words: phacoemulsification cataract extraction, diabetes, ocular surface, dry eye disease

叶善文, 邓锐东, 徐桂花, 杨杰华. 白内障超声乳化术对糖尿病患者眼表影响的研究进展[J]. 广州医药, 2023, 54(10): 112-119.

YE Shanwen, DENG Ruidong, XU Guihua, YANG Jiehua. Research progress on the effects of phacoemulsification on the ocular surface in patients with diabetes mellitus[J]. Guangzhou Medical Journal, 2023, 54(10): 112-119.

参考文献

[1] SAEEDI P,PETERSOHN I,SALPEA P,et al.Global and regional diabetes prevalence estimates for2019 and projections for 2030 and 2045:Results from the International Diabetes Federation Diabetes Atlas,9th edition[J].Diabetes Res Clin Pract,2019(157):107843.
[2] CRAIG J P,NICHOLS K K,AKPEK E K,et al.TFOS DEWS II definition and classification repor[J].Ocul Surf,2017,15(3):276-283.
[3] ROBERTS H W,DAY A C,O'BRART D P.Femtosecond laser-assisted cataract surgery:A review[J].Eur J Ophthalmol,2020,30(3):417-429.
[4] ROBERTS H W,WAGH V K,SULLIVAN D L,et al.A randomized controlled trial comparing femtosecond laser-assisted cataract surgery versus conventional phacoemulsification surgery[J].J Cataract Refract Surg,2019,45(1):11-20.
[5] JU R H,CHEN Y,CHEN H S,et al.Changes in ocular surface status and dry eye symptoms following femtosecond laser-assisted cataract surgery[J].Int J Ophthalmol,2019,12(7):1122-1126.
[6] SHAO D,ZHU X,SUN W,et al.Effects of femtosecond laser-assisted cataract surgery on dry eye[J].Experim Therapeutic Med,2018,16(6):5073-5078.
[7] AMESCUA G,AKPEK E K,FARID M,et al.Blepharitis preferred practice pattern®[J].Ophthalmology,2019,126(1):P56-P93.
[8] ISHRAT S,NEMA N,CHANDRAVANSHI S C L.Incidence and pattern of dry eye after cataract surgery[J].Saudi J Ophthalmol,2019,33(1):34-40.
[9] KOH S.Irregular astigmatism and higher-order aberrations in eyes with dry eye disease[J].Invest Ophthalmol Vis Sci,2018,59(14):DES36-DES40.
[10] EPITROPOULOS A T,MATOSSIAN C,BERDY G J,et al.Effect of tear osmolarity on repeatability of keratometry for cataract surgery planning[J].J Cataract Refract Surg,2015,41(8):1672-1677.
[11] Koh S,Tung C,Inoue Y,et al.Effects of tear film dynamics on quality of vision[J].Br J Ophthalmol,2018,102(12):1615-1620.
[12] ACHTSIDIS V,ELEFTHERIADOU I,KOZANIDOU E,et al.Dry eye syndrome in subjects with diabetes and association with neuropathy[J].Diabetes Care,2014,37(10):e210-e211.
[13] LV H,LI A,ZHANG X,et al.Meta-analysis and review on the changes of tear function and corneal sensitivity in diabetic patients[J].Acta Ophthalmol,2014,92(2):e96-e104.
[14] SHIMAZAKI J.Definition and diagnostic criteria of dry eye disease:historical overview and future directions[J].Investig Ophthalmol Vis Sci,2018,59(14):DES7-DES12.
[15] HAN S B,YANG H K,HYON J Y.Influence of diabetes mellitus on anterior segment of the eye[J].Clin Interv Aging,2018(14):53-63.
[16] MISRA S L,PATEL D V,MCGHEE C N,et al.Peripheral neuropathy and tear film dysfunction in type 1 diabetes mellitus[J].J Diabetes Res,2014(2014):848659.
[17] DOGRU M,KATAKAMI C,INOUE M.Tear function and ocular surface changes in noninsulin-dependent diabetes mellitus[J].Ophthalmology,2001,108(3):586-592.
[18] DEMILL D L,HUSSAIN M,POP-BUSUI R,et al.Ocular surface disease in patients with diabetic peripheral neuropathy[J].Br J Ophthalmol,2016,100(7):924-928.
[19] O’DONNELL C,EFRON N.Diabetes and contact lens wear[J].Clin Exp Optom,2012,95(3):328-337.
[20] LV H,LI A,ZHANG X,et al.Meta-analysis and review on the changes of tear function and corneal sensitivity in diabetic patients[J].Acta Ophthalmol,2014,92(2):e96-e104.
[21] CREUZOT-GARCHER C,LAFONTAINE P O,GUALINO O,et al.Etude des atteintes de la surface oculaire chez les patients diabétiques [Study of ocular surface involvement in diabetic patients][J].J Fr Ophtalmol,2005,28(6):583-588.
[22] BARTLETT J D,KEITH M S,SUDHARSHAN L,et al.Associations between signs and symptoms of dry eye disease:A systematic review[J].Clin Ophthalmol,2015(9):1719-1730.
[23] SONG P,SUN Z,REN S,et al.Preoperative management of MGD alleviates the aggravation of MGD and dry eye induced by cataract surgery:A prospective,randomized clinical trial[J].Biomed Res Int,2019(2019):2737968.
[24] VEHOF J S,SMITT-KAMMINGA N,NIBOURG S A,et al.Predictors of discordance between symptoms and signs in dry eye disease[J].Ophthalmology,2016(124):280-286.
[25] MIYAKE K,YOKOI N.Influence on ocular surface after cataract surgery and effect of topical diquafosol on postoperative dry eye:A multicenter prospective randomized study[J].Clin Ophthalmol,2017(11):529-540.
[26] DASGUPTA S,GUPTA R.The course of dry eye following phacoemulsification and manual-SICS:a prospective study based on Indian scenario[J].Int Eye Sci,2016,16(10):17891794.
[27] CHOI Y J,PARK S Y,JUN I,et al.Perioperative ocular parameters associated with persistent dry eye symptoms after cataract surgery[J].Cornea,2018,37(6):734-739.
[28] CHUANG J,SHIH K C,CHAN T,et al.Preoperative optimization of ocular surface disease before cataract surgery[J].Journal of Cataract and Refract Surg,2017,43(12):1596-1607.
[29] IGLESIAS E,SAJNANI R,LEVITT R C,et al.Epidemiology of persistent dry eye-like symptoms after cataract surgery[J].Cornea,2018,37(7):893-898.
[30] MIURA M,INOMATA T,NAKAMURA M,et al.Prevalence and characteristics of dry eye disease after cataract surgery:A systematic review and meta-analysis[J].Ophthalmol Ther,2022,11(4):1309-1332.
[31] ZHANG K,ZHAO L,ZHU C,et al.The effect of diabetes on corneal endothelium:a meta-analysis[J].BMC Ophthalmol,2021,21(1):78.
[32] KOHLI P,ARYA S K,RAI A,et al.Changes in ocular surface status after phacoemulsification in patients with senile cataract[J].Int Ophthalmol,2018,39(6):1345-1353.
[33] CETINKAYA S,MESTAN E,ACIR N O,et al.The course of dry eye after phacoemulsification surgery[J].BMC Ophthalmol,2015,15(1):68.
[34] GUPTA P K,DRINKWATER O J,VANDUSEN K W,et al.Prevalence of ocular surface dysfunction in patients presenting for cataract surgery evaluation[J].J Cataract Refract Surg,2018(44):1090-1096.
[35] TRATTLER W B,MAJMUDAR P A,DONNENFELD E D,et al.The prospective health assessment of cataract patients’ ocular surface(PHACO)study:The effect of dry eye[J].Clin Ophthalmol,2017(11):1423-1430.
[36] STARR C E,GUPTA P K,FARID M,et al.An algorithm for the preoperative diagnosis and treatment of ocular surface disorders[J].J Cataract Refract Surg,2019,45(5):669-684.
[37] LYNE A.Corneal sensitivity after surgery[J].Trans Ophthalmol Soc U K,1982,102(pt.2):302-305.
[38] JOHN T.Corneal sensation after small incision,sutureless,one-handed phacoemulsification[J].J Cataract Refract Surg,1995,21(4):425-428.
[39] KOHLHAAS M.Corneal sensation after cataract and refractive surgery[J].J Cataract Refract Surg,1998,24(10):1399-1409.
[40] KHANAL S,TOMLINSON A,ESAKOWITZ L,et al.Changes in corneal sensitivity and tear physiology after phacoemulsification[J].Ophthalmic Physiol Opt,2008,28(2):127-134.
[41] KIM J H,CHUNG J L,KANG S Y,et al.Change in corneal sensitivity and corneal nerve after cataract surgery[J].Cornea,2009,28(11):S20-S25.
[42] MARFURT C F,COX J,DEEK S,et al.Anatomy of the human corneal innervation[J].Exp Eye Res,2010,90(4):478-492.
[43] HOVANESIAN J A.The effect of lifitegrast on refractive accuracy,higher order aberrations,and symptoms in dry eye patients undergoing cataract surgery.In:Presented at American Society of Cataract and Refractive Surgery annual meeting,San Diego,CA,3-7 May 2019.
[44] SHIVITZ I A,ARROWSMITH P N.Corneal sensitivity after radial keratotomy[J].Ophthalmology,1988,95(6):827-832.
[45] LI X M,HU L,HU J,et al.Investigation of dry eye disease and analysis of the pathogenic factors in patients after cataract surgery[J].Cornea,2007,26(9 Suppl.1):S16-S20.
[46] APT L,ISENBERG S J,YOSHIMORI R,et al.Outpatient topical use of povidone-iodine in preparing the eye for surgery[J].Ophthalmology,1989,96(3):289-292.
[47] YILDIZ E,YENEREL N M,TURAN-YARDIMCI A,et al.Comparison of the clinical efficacy of topical and systemic azithromycin treatment for posterior blepharitis[J].J Ocul Pharmacol Ther,2018,34(4):365-372.
[48] GANESH S,BRAR S,BAGARE S N.Topical cyclosporine(0.05%)for management of dry eyes in patients undergoing cataract surgery-a comparative study[J].Open Ophthalmol J,2019,13(1):3442.
[49] CARETTI L,LA GLORIA VALERIO A,PIERMAROCCHI R,et al.Efficacy of carbomer sodium hyaluronate trehalose vs hyaluronic acid to improve tear film instability and ocular surface discomfort after cataract surgery[J].Clin Ophthalmol,2019(13):1157-1163.
[50] HORI Y.Secreted mucins on the ocular surface[J].Invest Ophthalmol Vis Sci,2018,59(14):DES151-DES156.
[51] WATANABE H.Medical treatment for dry eye in Japan[J].Invest Ophthalmol Vis Sci,2018,59(14):DES116-DES120.
[52] CUI L,LI Y,LEE H S,et al.Effect of diquafosol tetrasodium 3% on the conjunctival surface and clinical findings after cataract surgery in patients with dry eye[J].Int Ophthalmol,2018,38(5):2021-2030.
[53] JUN I,CHOI S,LEE G Y,et al.Effects of preservative-free 3% diquafosol in patients with pre-existing dry eye disease after cataract surgery:A randomized clinical trial[J].Sci Report,2019,9(1):12659.
[54] IGARASHI T,KOBAYASHI M,YAGUCHI C,et al.Efficacy of rebamipide instillation for contact lens discomfort with dry eye[J].Eye Contact Lens,2018,44Suppl 2(2):S137-S142.
[55] TONG A Y,PASSI S F,GUPTA P K.Clinical outcomes of lifitegrast 5% ophthalmic solution in the treatment of dry eye disease[J].Eye Contact Lens,2020,46Suppl1:S20-S24.
[56] HABER S L,BENSON V,BUCKWAY C J,et al.Lifitegrast:a novel drug for patients with dry eye disease[J].Ther Adv Ophthalmol,2019(11):2515841419870366.
[57] CHHABRA S,JERKINS J H,CONTO J E,et al.Lifitegrast ophthalmic solution for treatment of ocular chronic graft-versus-host disease[J].Leuk Lymphoma,2020,61(4):869-874.
[58] EGUCHI A,INOMATA T,NAKAMURA M,et al.Heterogeneity of eye drop use among symptomatic dry eye individuals in Japan:large-scale crowdsourced research using DryEyeRhythm application[J].Jpn J Ophthalmol,2021,65(2):271-281.
[59] PELS E,VRENSEN G F.Microbial decontamination of human donor eyes with povidone-iodine:Penetration,toxicity,and effectiveness[J].Br J Ophthalmol,1999,83(9):1019-1026.
[60] YANAI R,YAMADA N,UEDA K,et al.Evaluation of povidone-iodine as a disinfectant solution for contact lenses:Antimicrobial activity and cytotoxicity for corneal epithelial cells[J].Cont Lens Anterior Eye,2006,29(2):85-91.
[61] MOREIRA L B,KASETSUWAN N,SANCHEZ D,et al.Toxicity of topical anesthetic agents to human keratocytes in vivo[J].J Cataract Refract Surg,1999,25(7):975-980.
[62] ROSENWASSER G O.Complications of topical ocular anesthetics[J].Int Opthalmol Clin,1989,29(3):153-158.
[63] EPSTEIN S P,AHDOOT M,MARCUS E,et al.Comparative toxicity of preservatives on immortalized corneal and conjunctival epithelial cells[J].J Ocul Pharmacol Ther,2009,25(2):113-119.
[64] DART J.Corneal toxicity:the epithelium and stroma in iatrogenic and factitious disease[J].Eye(Lond),2003,17(8):886-892.
[65] JEE D,PARK M,LEE H J,et al.Comparison of treatment with preservative-free versus preserved sodium hyaluronate 0.1% and fluorometholone 0.1% eyedrops after cataract surgery in patients with preexisting dry-eye syndrome[J].J Cataract Refract Surg,2015,41(4):756-763.
[66] FOGAGNOLO P,FAVUZZA E,MARCHINA D,et al.New therapeutic strategy and innovative lubricating ophthalmic solution in minimizing dry eye disease associated with cataract surgery:A randomized prospective study[J].Adv Ther,2020,37(4):1664-1674.
[67] MIURA M,INOMATA T,NOJIRI S,et al.Clinical efficacy of diquafosol sodium 3% versus hyaluronic acid 0.1% in patients with dry eye disease after cataract surgery:a protocol for a single-centre,randomised controlled trial[J].BMJ Open,2022,12(1):e052488.
[68] YUSUFU M,LIU X,ZHENG T,et al.Hydroxypropyl methylcellulose 2% for dry eye prevention during phacoemulsification in senile and diabetic patients[J].Int Ophthalmol,2018,38(3):1261-1273.
[69] YOON D Y,KIM J H,JEON H S,et al.Evaluation of the protective effect of an ophthalmic viscosurgical device on the ocular surface in dry eye patients during cataract surgery[J].Korean J Ophthalmol,2019,33(5):467-474.
[70] HE Y,LI J,ZHU J,et al.The improvement of dry eye after cataract surgery by intraoperative using ophthalmic viscosurgical devices on the surface of cornea:The results of a consort-compliant randomized controlled trial[J].Medicine(Baltimore),2017,96(50):e8940.
[71] HWANG H B,KIM H S.Phototoxic effects of an operating microscope on the ocular surface and tear film[J].Cornea,2014,33(1):82-90.
[72] SAJNANI R,RAIA S,GIBBONS A,et al.Epidemiology of persistent postsurgical pain manifesting as dry eye-like symptoms after cataract surgery[J].Cornea,2018,37(12):1535-1541.
[73] CHO Y K,KIM M S.Dry eye after cataract surgery and associated intraoperative risk factors[J].Korean J Ophthalmol,2009,3(2):65-73.
[74] IPEK T,HANGA M P,HARTWIG A,et al.Dry eye following cataract surgery:The effect of light exposure using an in-vitro model[J].Cont Lens Ant Eye,2018,41(1):128-131.
[75] SZAKATS I,SEBESTYEN M,TOTH E,et al.Dry eye symptoms,patient-reported visual functioning,and health anxiety influencing patient satisfaction after cataract surgery[J].Current Eye Res,2017,42(6):832-836.
[76] GIANNACCARE G,PELLEGRINI M,SEBASTIANI S,et al.Efficacy of omega-3 fatty acid supplementation for treatment of dry eye disease:A meta-analysis of randomized clinical trials[J].Cornea,2019,38(5):565-573.
[77] ERGUN S B,SARIBAS G S,YARAYICI S,et al.Comparison of efficacy and safety of two tea tree oil-based formulations in patients with chronic blepharitis:A double-blinded randomized clinical trial[J].Ocul Immunol Inlflamm,2020,28(6):888-897.
[78] MOHAMMADPOUR M,MALEKI S,KHORRAMI-NEJAD M.The effect of tea tree oil on dry eye treatment after phacoemulsification cataract surgery:A randomized clinical trial[J].Eur J Ophthalmol,2020,30(6):1313-1319.
[79] MILLER D D,HASAN S A,SIMMONS N L,et al.Recurrent corneal erosion:A comprehensive review[J].Clin Ophthalmol,2019(13):325-335.
[80] BOURGES J L.Corneal dystrophies[J].J Fr Ophtalmol,2017,40(6):e177-e192.
[81] BOWEN R C,KOEPPEL J N,CHRISTENSEN C D,et al.The most common causes of eye pain at 2 tertiary ophthalmology and neurology clinics[J].J Neuroophthalmol,2018,38(3):320-327.
[82] MILJANOVIĆ B,DANA R,SULLIVAN D A,et al.Impact of dry eye syndrome on vision-related quality of life[J].Am J Ophthalmol,2007,143(3):409-415.
[83] POUYEH B,VITERI E,FEUER W,et al.Impact of ocular surface symptoms on quality of life in a United States veterans’ affairs population[J].Am J Ophthalmol,2012,153(6):1061-1066,e3.
[84] LI M,GONG L,CHAPIN W J,et al.Assessment of vision-related quality of life in dry eye patient[J].Invest Ophthalmol Vis Sci,2012,53(9):5722-5727.
[85] BOURNE R R,STEVENS G A,WHITE R A,et al.Causes of vision loss worldwide,1990-2010:A systematic analysis[J].Lancet Glob Health,2013,1(6):e339-e349.
[86] BOURNE R R,STEVENS G A,WHITE R A,et al.Causes of vision loss worldwide,1990-2010:a systematic analysis[J].Lancet Glob Health,2013,1(6):e339-349.
[87] DAY A C,DONACHIE P H,SPARROW J M,et al.The royal college of ophthalmologists’ national ophthalmology database study of cataract surgery:Report 1,visual outcomes and complications[J].Eye(Lond),2015,29(4):552-560.
[88] ADDISU Z,SOLOMON B.Patients’ preoperative expectation and outcome of cataract surgery at Jimma university specialized hospital-department of ophthalmology[J].Ethiop J Health Sci,2011,21(1):47-55.
[89] PAGER C K.Expectations and outcomes in cataract surgery:A prospective test of 2 models of satisfaction[J].Arch Ophthalmol,2004,122(12):1788-1792.